Dechra confirms completion on 16 January 2024. EQT lists a consortium of co-investors; an exclusive 100% EQT corporate stake is not established. Producing veterinary medicines is distinct from owning IVC or Medivet clinics. [1][2]
Headquarters, incorporation and tax residence describe different things. A headquarters address does not tell you where all of a company’s tax is paid.
Follow the investment
Investors in Dechra Pharmaceuticals
Investor disclosures found
Selected investor disclosures have been found. Each names the held entity, basis and date; the complete investor register remains outside this review. A stake in a parent or operating company is shown against that entity. Dates refer to each disclosure and can differ from the profile review date. Evidence links are included with each record.
Held entity · Dechra Pharmaceuticals consortium investment
EQT X and co-investors; individual stake not supplied
Ownership evidence checked ·
Dechra confirms completion on 16 January 2024. EQT lists a consortium of co-investors; an exclusive 100% EQT corporate stake is not established. Producing veterinary medicines is distinct from owning IVC or Medivet clinics.
This ownership research has not established a dated UK cash corporation-tax payment for the relevant reporting entity.
United KingdomNot yet verified
UK corporation tax paid
Not yet verifiedCash payment
Dechra Pharmaceuticals · UK reporting scope not verified Annual reporting period not yet verified
The sources establish investment or business information. The UK tax-paying entity, reporting period and cash corporation-tax payment have not been separately reconciled. Not verified does not mean no tax was paid. [1]
These figures have different scopes. They should not be added together or used as a like-for-like tax ranking.